AKAP12/Gravin gene expression in colorectal cancer: Clinical importance and review of the literature

Journal of B.U.ON.

Volumn 18, Issue 3, 2013, Pages 635-640

  Yildirim, Mustafa ^a   Suren, D ^b   Yildiz, M ^a   Sezgin Alikanoglu, A ^b   Eryilmaz, R ^b   Goktas, S ^a   Bulbuller, N ^b   Sezer, C ^a  

^a Antalya Education and Research Hospital   (Turkey)

^b Antalya Education and Research Hospital ^*  (Turkey)

Author keywords

AKAP12 Gravin; Anchoring proteins; Carcinogenesis; Colon cancer; Immunohistochemistry; Tumor suppressor gene

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INTESTINE EPITHELIUM; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

A KINASE ANCHOR PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885718942     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eser S, Yakut C, Özdemir R et al. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev 2010;11:1731-1739.
2. Tessema M, Willink R, Do K et al. Promoter methylation of genes in and round the candidate lung cancer susceptibility locus 6q23-25.Cancer Res 2008;68:1707-1714. (Pubitemid 351416555)
3. Choi MC, Jong HS, Kim TY et al. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 2004;23:7095-7103. (Pubitemid 39319171)
4. Flotho C, Paulun A, Batz C et al. AKAP12, a gene with tumor suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 2007;138:644-650. (Pubitemid 47206724)
5. Yildirim M, Paydas S, Tanriverdi K et al. Gravin gene expression in acute leukaemias: clinical importance and review of the literature. Leuk Lymphoma 2007;48:1167-1172. (Pubitemid 47009206)
6. Siegel R, Ward E, Brawley O et al. Cancer Statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-236.
7. Monsier JF, Perret AG, Vindimian M et al. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch Pathol Lab Med 1996; 120:654-659. (Pubitemid 26244391)
8. Nauert JB, Klauck TM, Langeberg LK et al. Gravin, an autoantigene recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 1997; 7:52-62. (Pubitemid 27058940)
9. Gelman IH. Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis. Genes Cancer 2010;1:1147-1156.
10. Turtoi A, Mottet D, Matheus N. The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis 2012;15:543-554.
11. Bilban M, Heintel D, Scharl T et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20:1080-1088. (Pubitemid 43797301)
12. Boultwood J, Pellagatti A, Watkins F et al. Low expression of the putative tumour suppressor gene Gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 2004; 126: 508-511. (Pubitemid 39093092)
13. Frankfort BJ, Gelman IH. Identification of Novel Cellular Genes Transcriptionally Suppressed by v-src. Biochem Biophys Res Commun 1995; 206: 916-926.
14. Xia W, Unger P, Miller L et al. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 2001; 61:5644-5651. (Pubitemid 32694952)
15. Wikman H, Kettunen E, Seppänen JK et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002; 21: 5804-5813. (Pubitemid 35333015)
16. Wasenius VM, Hemmer S, Kettunen E et al. Hepatocyte Growth Factor Receptor, Matrix Metalloproteinase-11, Tissue Inhibitor of Metalloproteinase-1, and Fibronectin Are Up-Regulated in Papillary Thyroid Carcinoma: A cDNA and Tissue Microarray Study. Clin Cancer Res 2003; 9: 68-75. (Pubitemid 36109717)
17. Huang S, Li Y Chen Y et al. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biol 2005;6:R84.
18. Lahav R, Suvà ML, Rimoldi D et al. Endothelin Receptor B Inhibition Triggers Apoptosis and Enhances Angiogenesis in Melanomas. Cancer Res 2004; 64: 8945-8953. (Pubitemid 39665502)
19. Liu W, Guan M, Su B et al. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer. Clin Chim Acta 2010;411:940-946.
20. Liu W, Guan M, Hu T et al. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro. PLoS One 2011;6:e24015.